SGHT - Sight Sciences, Inc.
IEX Last Trade
3.59
0.040 1.114%
Share volume: 4,138
Last Updated: Thu 26 Dec 2024 08:30:00 PM CET
Surgical and Medical Instrument Manufacturing :
1.09%
PREVIOUS CLOSE
CHG
CHG%
$3.55
0.04
1.13%
Fundamental analysis
42%
Profitability
60%
Dept financing
13%
Liquidity
75%
Performance
22%
Performance
5 Days
1.14%
1 Month
-10.80%
3 Months
-45.97%
6 Months
-43.83%
1 Year
-33.52%
2 Year
-69.58%
Key data
Stock price
$3.59
DAY RANGE
$3.55 - $3.60
52 WEEK RANGE
$3.56 - $8.45
52 WEEK CHANGE
-$35.80
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Paul Badawi
Region: US
Website: sightsciences.com
Employees: 210
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: sightsciences.com
Employees: 210
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Sight Sciences, Inc. engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. Its products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Recent news